[HTML][HTML] Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression

TL Larkins, M Nowell, S Singh, GL Sanford - BMC cancer, 2006 - Springer
Background Cyclooxygenase (COX) is the rate-limiting enzyme that catalyzes the formation
of prostaglandins. The inducible isoform of COX (COX-2) is highly expressed in aggressive …

Elevated cyclooxygenase-2 expression correlates with distant metastases in breast cancer

GS Ranger, V Thomas, A Jewell… - Anticancer Research, 2004 - ar.iiarjournals.org
Background: Cyclooxygenase-2 (COX-2) overexpression clearly plays an important role in
the pathogenesis of breast cancer. In this study, we analysed the relationship between COX …

Prognostic impact of cyclooxygenase-2 in breast cancer

C Denkert, KJ Winzer, S Hauptmann - Clinical breast cancer, 2004 - Elsevier
Abstract Cyclooxygenase (COX)—2, an inducible isoform of cyclooxygenases, regulates the
rapid production of high levels of prostaglandins during inflammation. Cyclooxygenase-2 is …

[HTML][HTML] Cyclooxygenase-2 and the inflammogenesis of breast cancer

RE Harris, BC Casto, ZM Harris - World journal of clinical oncology, 2014 - ncbi.nlm.nih.gov
Cohesive scientific evidence from molecular, animal, and human investigations supports the
hypothesis that constitutive overexpression of cyclooxygenase-2 (COX-2) is a ubiquitous …

[HTML][HTML] Cyclooxygenase-2 inhibition: effects on tumour growth, cell cycling and lymphangiogenesis in a xenograft model of breast cancer

NLP Barnes, F Warnberg, G Farnie, D White… - British journal of …, 2007 - nature.com
Abstract Cyclooxygenase-2 (COX-2) is associated with poor-prognosis breast cancer. We
used a nude mouse xenograft model to determine the effects of COX-2 inhibition in breast …

Silencing of cyclooxygenase-2 inhibits metastasis and delays tumor onset of poorly differentiated metastatic breast cancer cells

I Stasinopoulos, DR O'Brien, F Wildes, K Glunde… - Molecular Cancer …, 2007 - AACR
Cyclooxygenases (COX) are rate-limiting enzymes involved in the conversion of PLA2-
mobilized arachidonic acid into prostaglandins and thromboxanes. COX-2 is a key mediator …

Role of cyclooxygenase-2 in breast cancer

B Singh, A Lucci - Journal of Surgical Research, 2002 - journalofsurgicalresearch.com
Abstract Cyclooxygenase-2 (COX-2), the enzyme that converts arachidonic acid to
prostaglandin H 2, is expressed in normal brain and kidney, activated macrophages …

Elevated expression of cyclooxygenase‐2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma

C Denkert, KJ Winzer, BM Müller, W Weichert, S Pest… - Cancer, 2003 - Wiley Online Library
BACKGROUND Cyclooxygenases regulate the production of prostaglandins and play a role
in tumor development and progression. The authors investigated the prognostic impact of …

Cyclooxygenase-2 Inhibitor Induces Apoptosis in Breast Cancer Cells in an In vivo Model of Spontaneous Metastatic Breast Cancer

GD Basu, LB Pathangey, TL Tinder, M LaGioia… - Molecular Cancer …, 2004 - AACR
Abstract Cyclooxygenase-2 (COX-2) inhibitors are rapidly emerging as a new generation of
therapeutic drug in combination with chemotherapy or radiation therapy for the treatment of …

Cyclo-oxygenase 2 expression is associated with angiogenesis and lymph node metastasis in human breast cancer

C Costa, R Soares, JS Reis-Filho, D Leitao… - Journal of clinical …, 2002 - jcp.bmj.com
Aims: Cyclo-oxygenases 1 and 2 (COX-1 and COX-2) are key enzymes in prostaglandin
biosynthesis. COX-2 is induced by a wide variety of stimuli, and present during inflammation …